floxuridine has been researched along with Anemia in 2 studies
Floxuridine: An antineoplastic antimetabolite that is metabolized to fluorouracil when administered by rapid injection; when administered by slow, continuous, intra-arterial infusion, it is converted to floxuridine monophosphate. It has been used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract.
floxuridine : A pyrimidine 2'-deoxyribonucleoside compound having 5-fluorouracil as the nucleobase; used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract.
Anemia: A reduction in the number of circulating ERYTHROCYTES or in the quantity of HEMOGLOBIN.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, PY | 1 |
| Mai, HQ | 1 |
| Luo, DH | 1 |
| Qiu, F | 1 |
| Li, NW | 1 |
| Xiang, YQ | 1 |
| Chen, QY | 1 |
| Zhang, L | 1 |
| Sun, R | 1 |
| Cao, KJ | 1 |
| Guo, L | 1 |
| Deng, MQ | 1 |
| Mo, HY | 1 |
| Guo, X | 1 |
| Zhang, F | 1 |
| Cao, SM | 1 |
| Chen, MY | 1 |
| Guo, Y | 1 |
| Fan, YY | 1 |
| Hu, W | 1 |
| Hua, YJ | 1 |
| Xie, GF | 1 |
| Hong, MH | 1 |
| Takiuchi, H | 1 |
| Goto, M | 1 |
| Imamura, H | 1 |
| Furukawa, H | 1 |
| Imano, M | 1 |
| Imamoto, H | 1 |
| Kimura, Y | 1 |
| Ishida, H | 1 |
| Fujitani, K | 1 |
| Narahara, H | 1 |
| Shimokawa, T | 1 |
2 trials available for floxuridine and Anemia
| Article | Year |
|---|---|
Induction-concurrent chemoradiotherapy versus induction chemotherapy and radiotherapy for locoregionally advanced nasopharyngeal carcinoma.
Topics: Adult; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therap | 2009 |
Multi-center phase II study for combination therapy with paclitaxel/doxifluridine to treat advanced/recurrent gastric cancer showing resistance to S-1 (OGSG 0302).
Topics: Adenocarcinoma; Aged; Anemia; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Disease-Free | 2008 |